Investing Profile

Nina Kjellson

VCInvestor
General Partner at Canaan Partners
canaan.com/team/nina-kjellsonMenlo Park, California
Photo of Nina Kjellson, General Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Canaan Partners General Partner
$250K - $20.0M
$10.0M
37
$800M
CompanyStageDateRound SizeTotal Raised
Actio Biosciences
Series BJun 2025$66M
Series ASep 2023$55M
$120M
Co-investors: Jason Fuller (Deerfield Management)
Rondo Therapeutics
Series AMar 2022$67M
$67M
Tyra Biosciences
Series BMar 2021$110M
Series AJan 2020$50M
$360M
Co-investors: Melissa McCracken (Nextech Invest), Jake Simson (RA Capital)
Vineti
Series COct 2020$33M
Series CFeb 2020$35M
Series BApr 2018$34M
$100M
Co-investors: Mike Pellini (Section 32), Eli Casdin (Casdin Capital), Marc Benioff
Trishula Therapeutics
Series UnknownAug 2020
Intrepida Bio
Series AOct 2019$10M
$10M
Dauntless Pharmaceuticals
Series AFeb 2017$25M
$37M
Co-investors: David Kabakoff (HealthQuest Capital)
Welltok
Series EOct 2016$34M
Series DJan 2015$37M
Series CFeb 2014$22M
Series BApr 2013$19M
$240M
Co-investors: Mohamad Makhzoumi (New Enterprise Associates (NEA)), Kevin Spain (Emergence Capital), Blake Wu (New Enterprise Associates (NEA)), Lily Huang (New Enterprise Associates (NEA)), Sharon Stevenson (Okapi Venture Capital), Michael Greeley (Flare Capital Partners), Bruce Hallett (Miramar Ventures)